Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of High-risk Soft Tissue Sarcoma
Clinical trial NCT04606108 · UNKNOWN
Trial details
- NCT number
- NCT04606108
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-19
- Primary completion
- 2021-10-19
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.